Evolva Holding SA (EVE) - Total Assets
Based on the latest financial reports, Evolva Holding SA (EVE) holds total assets worth CHF6.76 Million CHF (≈ $8.54 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Evolva Holding SA - Total Assets Trend (2005–2025)
This chart illustrates how Evolva Holding SA's total assets have evolved over time, based on quarterly financial data. Also see how much is Evolva Holding SA worth for the company's overall valuation and market capitalisation.
Evolva Holding SA - Asset Composition Analysis
Current Asset Composition (December 2025)
Evolva Holding SA's total assets of CHF6.76 Million consist of 100.0% current assets and 0.0% non-current assets. Review EVE total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (CHF) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF0.00 | 83.0% |
| Accounts Receivable | CHF632.30K | 9.4% |
| Inventory | CHF0.00 | 0.0% |
| Property, Plant & Equipment | CHF0.00 | 0.0% |
| Intangible Assets | CHF0.00 | 0.0% |
| Goodwill | CHF0.00 | 0.0% |
Asset Composition Trend (2005–2025)
This chart illustrates how Evolva Holding SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See EVE share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Evolva Holding SA's current assets represent 100.0% of total assets in 2025, an increase from 93.1% in 2005.
- Cash Position: Cash and equivalents constituted 83.0% of total assets in 2025, down from 90.3% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2005.
- Asset Diversification: The largest asset category is accounts receivable at 9.4% of total assets.
Evolva Holding SA Competitors by Total Assets
Key competitors of Evolva Holding SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
New Providence Acquisition Corp. III Class A Ordinary Shares
NASDAQ:NPAC
|
USA | $310.81 Million |
|
Live Oak Acquisition Corp. V Class A Ordinary Shares
NASDAQ:LOKV
|
USA | $240.47 Million |
|
OneIM Acquisition Corp. Class A Ordinary Shares
NASDAQ:OIM
|
USA | $293.03 Million |
|
ProCap Acquisition Corp Class A Ordinary Shares
NASDAQ:PCAP
|
USA | $261.20 Million |
|
Jackson Acquisition Company II
NYSE:JACS
|
USA | $245.21 Million |
|
Graf Global Corp
NYSE MKT:GRAF
|
USA | $243.44 Million |
|
Pyrophyte Acquisition Corp. II
NYSE:PAII
|
USA | $206.36 Million |
|
SPACSphere Acquisition Corp. Class A Ordinary Shares
NASDAQ:SSAC
|
USA | $175.44 Million |
Evolva Holding SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.31 | 7.98 | 2.22 |
| Quick Ratio | 8.31 | 8.69 | 1.62 |
| Cash Ratio | 0.00 | 7.14 | 1.30 |
| Working Capital | CHF5.94 Million | CHF6.60 Million | CHF18.44 Million |
Evolva Holding SA - Advanced Valuation Insights
This section examines the relationship between Evolva Holding SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.17 |
| Latest Market Cap to Assets Ratio | 1.03 |
| Asset Growth Rate (YoY) | -10.4% |
| Total Assets | CHF6.76 Million |
| Market Capitalization | $6.95 Million USD |
Valuation Analysis
Above Book Valuation: The market values Evolva Holding SA's assets above their book value (1.03x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Evolva Holding SA's assets decreased by 10.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Evolva Holding SA (2005–2025)
The table below shows the annual total assets of Evolva Holding SA from 2005 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CHF6.76 Million ≈ $8.54 Million |
-10.41% |
| 2024-12-31 | CHF7.54 Million ≈ $9.53 Million |
-23.27% |
| 2023-12-31 | CHF9.83 Million ≈ $12.43 Million |
-92.50% |
| 2022-12-31 | CHF131.01 Million ≈ $165.63 Million |
-16.11% |
| 2021-12-31 | CHF156.17 Million ≈ $197.45 Million |
-6.42% |
| 2020-12-31 | CHF166.89 Million ≈ $211.00 Million |
-13.11% |
| 2019-12-31 | CHF192.08 Million ≈ $242.84 Million |
-9.83% |
| 2018-12-31 | CHF213.02 Million ≈ $269.31 Million |
-11.18% |
| 2017-12-31 | CHF239.82 Million ≈ $303.20 Million |
+20.98% |
| 2016-12-31 | CHF198.24 Million ≈ $250.62 Million |
-14.64% |
| 2015-12-31 | CHF232.24 Million ≈ $293.61 Million |
+9.23% |
| 2014-12-31 | CHF212.61 Million ≈ $268.80 Million |
+101.97% |
| 2013-12-31 | CHF105.27 Million ≈ $133.09 Million |
+16.49% |
| 2012-12-31 | CHF90.37 Million ≈ $114.26 Million |
-15.14% |
| 2011-12-31 | CHF106.50 Million ≈ $134.64 Million |
+41.95% |
| 2010-12-31 | CHF75.02 Million ≈ $94.85 Million |
-19.24% |
| 2009-12-31 | CHF92.90 Million ≈ $117.45 Million |
+109.44% |
| 2008-12-31 | CHF44.36 Million ≈ $56.08 Million |
-48.74% |
| 2007-12-31 | CHF86.53 Million ≈ $109.40 Million |
+3.31% |
| 2006-12-31 | CHF83.75 Million ≈ $105.89 Million |
-38.26% |
| 2005-12-31 | CHF135.65 Million ≈ $171.50 Million |
-- |
About Evolva Holding SA
EvoNext Holdings SA is in the process of liquidation of its remaining assets. Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. The company was formerly known as Evolva Holding SA… Read more